96 related articles for article (PubMed ID: 8321880)
1. Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines.
Bojarski AJ; Cegła MT; Charakchieva-Minol S; Mokrosz MJ; Maćkowiak M; Misztal S; Mokrosz JL
Pharmazie; 1993 Apr; 48(4):289-94. PubMed ID: 8321880
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
[TBL] [Abstract][Full Text] [Related]
3. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of CNS agents, Part 20: 9-(omega-[1-(m-chlorophenyl)-4-piperazinyl]alkyl]-1,2,3,4-tetra-hydro- beta-carbolines: new 5-HT1A and 5-HT2A receptor ligands.
Boksa J; Duszynńska B; Mokrosz JL
Pharmazie; 1995 Mar; 50(3):220-1. PubMed ID: 7732057
[No Abstract] [Full Text] [Related]
5. Structure-activity relationship studies of CNS agents. Part VII. The effect of the imidazole fragment in 2-substituted 1-[3-(4-aryl-1-piperazinyl)propyl]imidazoles on their interaction modes with 5-HT1A and 5-HT2 receptors.
Mokrosz JL; Duszyńska B
Pol J Pharmacol Pharm; 1992; 44(5):527-38. PubMed ID: 1297115
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site.
Mokrosz JL; Bojarski AJ; Maćkowiak M; Bielecka Z; Boksa J
Pharmazie; 1994 May; 49(5):328-33. PubMed ID: 8016178
[TBL] [Abstract][Full Text] [Related]
7. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of CNS agents. Part 16: A lower limit of a distance between crucial pharmacophores of 5-HT1A ligands.
Mokrosz JL; Mokrosz MJ; Bojarski AJ; Charakchieva-Minol S
Pharmazie; 1994 Oct; 49(10):781-2. PubMed ID: 7816905
[No Abstract] [Full Text] [Related]
10. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
Mokrosz MJ; Kowalski P; Kowalska T; Majka Z; Duszyńska B; Charakchieva-Minol S; Szaro A; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
[TBL] [Abstract][Full Text] [Related]
11. Lack of activity of azapropazone in the hot-plate test and in 5-HT1A and 5-HT2 receptor subtypes in rat brain membranes.
Pini LA; Sandrini M; Vitale G
Drugs Exp Clin Res; 1995; 21(5):181-6. PubMed ID: 8846748
[TBL] [Abstract][Full Text] [Related]
12. Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
Khorana N; Smith C; Herrick-Davis K; Purohit A; Teitler M; Grella B; Dukat M; Glennon RA
J Med Chem; 2003 Aug; 46(18):3930-7. PubMed ID: 12930153
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
[TBL] [Abstract][Full Text] [Related]
14. Stereoselectivity of 8-OH-DPAT toward the serotonin 5-HT1A receptor: biochemical and molecular modeling study.
Dabrowska J; Brylinski M
Biochem Pharmacol; 2006 Aug; 72(4):498-511. PubMed ID: 16796994
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
Höök BB; Cortizo L; Johansson AM; Westlind-Danielsson A; Mohell N; Hacksell U
J Med Chem; 1996 Sep; 39(20):4036-43. PubMed ID: 8831769
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
Boksa J; Charakchieva-Minol S; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.
Andronati S; Sava V; Makan S; Kolodeev G
Pharmazie; 1999 Feb; 54(2):99-101. PubMed ID: 10084155
[TBL] [Abstract][Full Text] [Related]
20. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
Monte AP; Marona-Lewicka D; Parker MA; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1996 Jul; 39(15):2953-61. PubMed ID: 8709129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
